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Purpose: To compare the clinical outcome of AT‐45 implantation between high myopic eyes and non‐high 
myopic eyes. 
Methods: Retrospective, non‐randomized, comparative trial. The medical charts of 28 patients with 35 eyes 
who had phacoemulsification and AT‐45 implantation were retrospectively reviewed. 13 eyes of 10 patients 
were included in the high myopic group (axial length ≥ 26.0 mm) and 22 eyes of 18 patients were included 
in the non‐high myopic group. The clinical data included unilateral best‐corrected visual acuity (BCVA) and 
distance‐corrected near visual acuity (DCNVA) at 6‐months follow‐up after the surgery. The results were 
compared between the two groups.
Results: In the non‐high myopic group, 22 eyes (100%) and 19 eyes (86.4%) achieved a BCVA of 20/25 
and 20/20 or better respectively. For the high myopic group, the results were 13 eyes (100%) and 12 eyes 
(92.3%) respectively, at 6 months after the surgery. In the non‐high myopic group, 21 (95.4%) and 7 eyes 
(31.8%) achieved a DCNVA of 20/40 and 20/25 or better. For the high myopic group, the results were 13 
(100%) and 4 eyes (30.8%) respectively, at 6 months after the surgery, the differences between the two 
groups for a BCVA of 20/25 or better and 20/20 or better and a DCNVA 20/40 or better and 20/25 or better 
were not statistically significant.
Conclusions: Six months clinical outcome of cataract surgery with an AT‐45 for the high myopic eyes was 
satisfactory; it was not significantly different from that of the non‐high myopic eyes.
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Over the past several decades, cataract surgical technique 
and intraocular lens (IOL) technology developed dramatically. 
Many of the surgical complications have been resolved. 
However, despite the excellent restoration of visual acuity 
and the biocompatibility of the IOLs, the postoperative near 
vision in the pseudophakic eye remains unsatisfactory. 
Therefore, most of the patients who have cataract extraction 
require glasses for near vision. To solve this problem, 
technologies for restoring near vision have been investigated 
and special IOLs have been developed.
1‐4
A recently developed accommodative IOL, the AT‐45 
(Eyeonics Vision, USA) has shown satisfactory clinical 
results and obtained U.S. Food and Drug Administration 
(FDA) approval in November 2003. However, in a FDA 
approved clinical trial, the longest axial length was only 26.6 
mm and the clinical outcome after AT‐45 implantation for 
high myopic eye has not been studied.
The purpose of this report was to evaluate the clinical 
outcome after AT‐45 implantation for high myopic eyes and 
compare the results with non‐high myopic eyes. Previously, 
we reported clinical outcome of the AT‐45 in non‐high 
myopic eyes.
5 The same eyes of the previous study were 
included in the control group in this study.
Materials and Methods
The medical records of 29 patients with 36 treated eyes, 
who had phacoemulsification and AT‐45 implantation with a 
minimum follow up of 6 months were retrospectively 
reviewed. None of the patients had a prior history of ocular 
trauma, eye surgery, intraocular inflammation, glaucoma, 
prominent retinal abnormalities or other ocular lesions that 
could affect the visual outcome. For the IOL power 
calculation, the immersion type A‐scan biometer (Hiscan, 
Optikon, Italy), a manual keratometer (OM‐4, Topcon, Japan) Kor J Ophthalmol Vol.22, No.2, 2008
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Table 1. Patients’ demographics 
Non‐high myopic group High myopic group P‐value
Male / female (number of eyes) 14/8 6/7 0.0
†
Age (years) 51.8±8.75* 46.2±8.47* 0.048
‡
Axial length (mm) 24.4±1.01* 27.9±1.38* 0.000
‡
Preoperative manifest refraction (diopter) ‐1.9±2.0* ‐9.6±3.2* 0.000
‡
Preoperative visual acuity (logMAR) 0.56±0.37*  1.1±0.23* 0.000
‡
Preoperative visual acuity with glasses (logMAR) 0.29±0.19* 0.47±0.30* 0.049
‡
Implanted IOL (diopter) 19.1±3.22* 13.7±4.21* 0.000
‡
Predicted postoperative refraction (diopter) ‐0.33±0.19* ‐0.98±1.15* 0.047
‡
* Mean±Standard deviation; 
† Chi‐Square test; 
‡ Independent samples T‐test.
and the SRK/T calculation formula were used for the 
assessments. Eyes with an axial length of 26.0 mm or more 
were included in the ‘high myopic group’ and all others were 
included in the ‘non‐high myopic group’. The results of the 
non‐high myopic group were used as a ‘control’ for 
evaluating the clinical outcome of AT‐45 implantation in the 
high myopic eyes. Four eyes in the high myopic group, the 
target refraction was selected to be myopic, with the patients’ 
agreement, because the lowest commercially available power 
of AT‐45 was only +10.0 diopter (D).
One surgeon, ES Chung, performed all of the procedures, 
which were carried out using topical anesthesia. A 3.5 
mm temporal clear corneal incision was performed and 
the capsulorhexis was sized at 5.0~5.5 mm. Careful 
phacoemulsification and polishing of the capsule were carried 
out to prevent posterior capsular rupture and opacity. During 
the operation, a proper volume of viscoelastic material was 
injected into the chamber to avoid hyperinflation of the 
posterior capsule. After the AT‐45 was implanted into the 
capsular bag, the incision site was closed with 1 bite of a 
10‐0 nylon suture (Alcon, USA) to avoid postoperative 
aqueous leakage. Two hours after the surgery, slit lamp 
examination was performed to assess the IOP, postoperative 
aqueous leakage and the IOL position.
Postoperative medications included 0.5% levofloxacin 
(Cravit, Santen, Japan), prednisolone acetate (1% Predforte, 
Allergan, USA) and cyclopentolate HCL (1% Cyclogyl, 
Alcon, USA). One drop of atropine (1% Ocutropine, Samil, 
Korea) was applied just after the surgery and cyclopentolate 
was used for 10 days after the surgery. Two weeks after the 
procedure, all the patients received near vision training. 
Postoperative evaluations including the slit lamp examination, 
manifest refraction (at 2 weeks, 1, 2 and 6 months following 
surgery), best‐corrected visual acuity (BCVA) and distance‐
corrected near visual acuity (DCNVA), which is near visual 
acuity with distance correction (at 6 months after surgery) 
were performed. Distance and near visual acuities were 
measured with the ETDRS visual acuity chart and the Jaeger 
chart respectively. All the study outcomes were compared 
between the high myopic and non‐high myopic groups.
Statistical analysis was performed using a commercially 
available statistical package (SPSS ver. 11.5 for Windows; 
SPSS Sciences, Chicago, USA). Differences in the BCVA 
and the DCNVA between the two groups were evaluated 
with the Fisher’s exact test. The independent samples T‐test 
was used to evaluate changes in the SE between the two 
groups. For all statistical analyses, a P<0.05 was considered 
significant.
Results
Twenty three eyes of 19 patients were classified as non‐
high myopic (axial length < 26.0 mm) and 13 eyes of 10 
patients were considered high myopic (axial length ≥ 26.0 
mm). All the operations were successful without any 
intraoperative complications. Complications such as immediate 
postoperative aqueous leaking or IOL decenteration were not 
observed. One eye of the non‐high myopic group showed 
+1.5D of hyperopic shift at 2 weeks following surgery. 
The patient complained about visual disturbance and 
piggybacking using monofocal IOL was performed at 4 
weeks following the initial surgery. This case was included 
in the analysis of complication and predictability, but 
excluded from the visual acuity and spherical equivalent 
analysis. Therefore, 22 eyes of 19 patients were included in 
the non‐high myopic group for visual acuity and spherical 
equivalent analysis.
The mean age of the patients was 51.8±8.8 years (range 
38 to 72 years) in the non‐high myopic group and 46.2±8.5 
years (range 29 to 61 years) in the high myopic group 
(Independent samples T‐test, P=0.048). The mean axial length 
was 24.4±1.0 mm and 27.9±1.4 mm (Independent samples T‐
test, P=0.000), the mean implanted IOL power was 19.1±3.2 
D and 13.7±4.2D (Independent samples T‐test, P=0.000) and 
the mean predicted postoperative refraction was ‐0.33±0.19D 
and  –0.98 ±1.15D respectively (Independent samples T‐test, 
P=0.047) (Table 1).
Six months after the surgery, a BCVA of 20/25 or better 
was achieved in 22 (100%) of the non‐high myopic group 
and in 13 (100%) of the high myopic group. JH Kim, et al. ACCOMMODATIVE IOLs IN HIGH MYOPIC EYES   
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Table 2. Mean spherical equivalent (SE) change after AT‐45 implantation in the non‐high myopic group (n=22) 
and the high myopic group (n=13), during follow‐up (F/U). The difference in SE between postoperative 2 weeks 
and 6 months was not statistically significant in comparison between the two groups (P=0.429)
F/U period Non‐high myopic group High myopic group P‐value
Mean±SD (diopter)
SE 2W ‐0.25±0.48 ‐0.92±1.06
1M ‐0.22±0.29 ‐0.57±0.97
2M ‐0.14±0.39  ‐0.47±1.03
6M ‐0.16±0.36 ‐0.64±0.89
Change of SE 2W~6M 0.09±0.39 0.28±0.67 0.429*
* Independent samples T‐test; SD=standard deviation; W=week; M=month.
Fig. 1. Best‐corrected distance visual acuity in the non‐high 
myopic group (n=22) and the high myopic group (n=13), 6 
months after AT‐45 implantation.
Fig. 2. Distance‐corrected near visual acuity in the non‐high 
myopic group (n=22) and in the high myopic group (n=13), 6 
months after AT‐45 implantation.
A BCVA of 20/20 or better was achieved in 19 (86.4%) 
of the non‐high myopic group, and in 12 (92.3%) of the high 
myopic group (Fig. 1). A DCNVA of 20/40 or better was 
achieved in 21 (95.4%) of the non‐high myopic group, and 
in 13 (100%) of the high myopic group. A DCNVA of 20/25 
or better was achieved in 7 (31.8%) of the non‐high myopic 
group and in 4 (30.8%) of the high myopic group (Fig. 2). 
Differences among the non‐high myopic and high myopic 
groups in achieving the BCVA of 20/25 or better (Fisher’s 
exact test, P=1.000) and 20/20 or better (Fisher’s exact test, 
P=1.000) were not statistically significant. In addition, the 
differences in the DCNVA of 20/40 or better (Fisher’s exact 
test,  P=1.000) and a 20/25 or better (Fisher’s exact test, 
P=1.000) were not statistically significant.
The mean spherical equivalent (SE) change during the 
follow up period was ‐0.25±0.48D (2 weeks), ‐0.22±0.29D (1 
month), ‐0.14±0.39D (2 months) and ‐0.16±0.36D (6 months) 
in the non‐high myopic group and –0.92±1.06D (2 weeks), 
‐0.57±0.97D (1 month), ‐0.47±1.03D (2 months), ‐0.64±0.89D 
(6 months) in the high myopic group. The mean SE 
difference between postop 2 weeks and 6 months 
postoperatively was 0.09±0.39D in the non‐high myopic 
group and 0.28±0.67D in the high myopic group (Table 2). 
The SE difference, in comparison between the two groups, 
was not statistically significant (Independent samples T‐test, 
P=0.429).Kor J Ophthalmol Vol.22, No.2, 2008
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For the non‐high myopic and high myopic groups, 20 eyes 
(90.9%) and 12 eyes (92.3%) were within 1.0D of the 
predicted postoperative SE (Fisher’s exact test, P=1.000) and 
17 eyes (72.7%) and 8 eyes (61.5%) were within 0.5D of the 
predicted postoperative SE respectively (Fisher’s exact test, 
P=0.888).
There was no acute postoperative abnormality by slit lamp 
biometry observed in any of the cases. In the non‐high 
myopic group, postoperative complications were noted in 7 
eyes (31.8%). As mentioned above, one case of significant 
postoperative hyperopic shift accompanied with posterior 
capsular fold was noted in 1 eye. Five cases had posterior 
capsular opacities develop and 3 cases required Nd:YAG 
laser posterior capsulotomy. One case had posterior synechia 
develop, which treated successfully by synechiolysis using a 
clear corneal incision. In the high myopic group, 
postoperative complications were noted in 3 eyes (23.1%). 
Two cases had posterior capsular opacities develop but they 
did not require further treatment. One case had asymmetric 
vaulting with posterior capsular fibrosis and contraction 
developed at 1 month post surgery. After Nd:YAG laser 
posterior capsulotomy, the position of the IOL was 
normalized.
Discussion
Theoretically, the accommodation after cataract surgery 
with monofocal IOL implantation is not sufficient to achieve 
satisfactory near vision. However, despite the pseudophakic 
state, there are some cases with good postoperative near 
vision. This phenomenon is not a ‘true‐accommodation’ but 
rather a ‘pseudo‐accommodation’, that is associated with the 
pupil size, residual myopia and astigmatism.
6,7
Cumming and Kammann postulated that the increased 
anterior vitreous pressure, which is triggered by contraction 
and mass redistribution of the ciliary body, could change the 
refractive power of the eye. This can occur by inducing 
anterior movement of the IOL, and AT‐45 was developed 
based on this hypothesis.
8‐12 Several studies have been 
reported that support this hypothesis by demonstrating intra‐
ocular movement of IOL.
13,14 However, the true mechanism 
of action of the AT‐45 has not been confirmed.
Although still debated, the overall reported clinical 
outcome after the AT‐45 implantation has been relatively 
satisfactory.
12,15‐20 When compared with other available IOLs 
for near vision, the AT‐45 has shown similar or better near 
vision performance.
20‐24 However, the visual outcome after 
cataract surgery may be influenced by various factors related 
to the patient and surgeon and the methods and location of 
patient evaluation at follow‐up. Furthermore, for the recently 
developed IOL, the study population to date may still be 
small and the follow‐up period short. Therefore, such 
limitations must be considered when interpreting the reported 
study results.
Previously, most of the patients who received an AT‐45 
implantation had a normal axial length. According to the 
manufacturer’s instructions (Crystalens vision enhancement 
course material, Eyeonics, Inc., 2004), there is a weak 
correlation between the axial length and the accommodative 
effect and the clinical outcome in myopic eyes was said to 
be as good as that of the non‐myopic eyes. However in the 
FDA clinical trial, the highest axial length was only 26.6 
mm. In addition, the function of the AT‐45 was not 
sufficiently evaluated in high myopic eyes.
19 After FDA 
approval, even until recently, the clinical outcome of AT‐45 
in high‐myopic eyes has not been reported. In the United 
States and Europe, only a small portion of the population has 
high myopia. However, the incidence of high myopia in Asia 
is much higher than in other ethnic groups.
25‐28 Therefore, the 
evaluation of the AT‐45 in high myopic eyes is especially 
important for Asian populations. The conventional definition 
of high myopia is a SE of less than –6.0D. In our study, to 
exclude lenticular myopia, we defined high myopia as an 
axial length of 26.0 mm or more, according to the Pericival’s 
definition.
29
In this study, the postoperative distance and near visual 
acuity as well as predictability of the postoperative refraction 
of the high myopic eyes were satisfactory and were not 
significantly different from those of the non‐high myopic 
eyes. Compared to emmetropic eyes, high myopic eyes have 
several distinct characteristics, which may have adverse 
effects on the clinical outcome after AT‐45 implantation. 
High myopic eyes typically have a deeper anterior chamber 
and the vitreous body is frequently more liquefied than in a 
similar‐aged emmetrope. Therefore, excessive anterior 
chamber deepening and hyperinflation of the posterior 
capsule may occur during surgery. According to the 
manufacturer’s instructions (Crystalens vision enhancement 
course material, Eyeonics, Inc., 2004), hyperinflation of the 
posterior capsule may change the post‐operative refraction 
leading to a more hyperopic result by influencing the position 
of the AT‐45. Moreover, the IOL power determination in 
high myopic eyes is relatively inaccurate and this may lead 
to postoperative hyperopia resulting in a significant effect on 
the near vision. In order to reduce this possible error, we 
chose the immersion type A‐scan biometry for axial length 
measurement, which has several advantages over contact type 
A‐scan biometry.
30,31 All A‐scan biometry was performed by 
one experienced technician. We applied the SRK/T formula 
for both non‐high myopic and high‐myopic groups based on 
the recommended calculation formula for AT‐45 implantation 
with SRK‐T (Crystalens vision enhancement course material, 
Eyeonics, Inc., 2004). This formula is also recommended for 
eyes with axial myopia.
32,33
Prior reports have demonstrated that the accommodative 
range induced by forward IOL movement varies depending 
on the axial length and power of the implanted IOL. Short 
eyes with high IOL power have shown a more effective 
accommodation with an IOL shift.
34 Therefore, the results of 
this study suggest that pseudoaccommodation may partially JH Kim, et al. ACCOMMODATIVE IOLs IN HIGH MYOPIC EYES   
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affect near vision after AT‐45 implantation.
The findings of this study showed that both groups had 
continuous hyperopic changes for the first 2 months after the 
surgery. Although the changes were slightly more prominent 
in the high myopic group, the differences between the two 
groups were not statistically significant. Because the target 
refractions were myopic in 4 eyes, in the high myopic group, 
the mean SE of the high myopic group had a more negative 
value than that of the non‐high myopic group. However, the 
difference in the SE at 2 weeks and 6 months after surgery 
was not statistically significant in comparison between the 
two groups.
The overall complication rates in the two groups were 
similar. A relatively high incidence of a posterior capsular 
opacity was noted in both groups. However, less than half 
of the cases complained of decreased visual acuity. In the 
high myopic group, one case of asymmetric vaulting with 
posterior capsular contraction developed, which is a specific 
complication of AT‐45 implantation.
35,36 Prior reports have 
shown asymmetric vaulting at 3 weeks
35 and 6 months36 
after surgery. Asymmetric bag fibrosis
35 and central posterior 
capsular opacity with a fibrotic band
36 was suspected as the 
cause of the IOL vaulting. Similarly, posterior capsular 
fibrosis and contraction was noted in our cases, this was 
successfully treated with Nd:YAG laser posterior capsulotomy. 
One eye in the non‐high myopic group showed significant 
hyperopic shift two weeks postoperatively. This may be 
attributed to the contraction of posterior capsule, although the 
reason of this finding was not clearly revealed yet, as 
mentioned in a previous report.
5
It has been several years since FDA approved AT‐45 
implantation. However, the performance and complications 
associated with AT‐45 implantation are not yet fully 
understood. The results of our study showed that AT‐45 
implantation for high myopic eyes was safe and effective and 
the outcomes were not significantly different from non‐high 
myopic eyes. Further studies with a larger patient population 
and a prospective and randomized study design as well as a 
longer follow up are required for confirmation of the clinical 
outcome after AT‐45 implantation in high myopic eyes.
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